TipRanks
Sinovac Biotech (SVA)
NASDAQ:SVA
US Market
SVA
Sinovac Biotech
RESEARCH TOOLSreports
Want to see SVA full AI Analyst Report?

Sinovac Biotech (SVA) Balance Sheet

137 Followers

Sinovac Biotech Balance Sheet

Sinovac Biotech's total assets for Q1 2024 were $13.66B, a decrease of -0.49% from the previous quarter. SVA total liabilities were $1.64B for the fiscal quarter, a 9.91% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 23Dec 22Dec 21Dec 20
Total Assets
$ 8.64B$ 13.66B$ 14.11B$ 16.75B$ 1.90B
Total Liabilities
$ 2.23B$ 1.64B$ 1.40B$ 2.87B$ 781.20M
Total Equity Gross Minority
$ 6.40B$ 12.02B$ 12.71B$ 13.88B$ 1.12B
Other Metrics
Currency in USD

Sinovac Biotech Debt to Assets